- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06801691
The Next Step Towards the Elimination of Iodine Deficiency and Preventable Iodine-related Disorders in Europe (EUthyroid2)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Detailed Description:
BACKGROUND: Iodine deficiency (ID) is a leading risk factor for thyroid disorders and developmental impairments in offspring. It is recognized as one of the most preventable causes of mental impairment in children. The EUthyroid2 project aims to contribute to the prevention of ID and its associated symptoms and disease burden in adolescents across Europe and beyond.
AIM: This project seeks to develop and implement an educational intervention in various educational settings, effectively raising awareness of the risks associated with iodine deficiency.
METHODS: The intervention will be conducted in each participating country, with three clusters (secondary schools, high schools, and vocational schools) per country. The goal is to achieve a final sample of 4500 study participants in all countries combined, involving one baseline measurement and two follow-up assessments (2-4 weeks and 6-8 months post-intervention). Data will be collected at all measurement points, with variations in implementation accounted for due to differences between countries. To ensure the intervention's functionality and effectiveness, the project will consider recommendations for developing complex interventions, appropriate theoretical frameworks, and conduct a context analysis. Outcome measures will include a newly developed iodine awareness questionnaire (primary outcome) and an iodine-specific food frequency questionnaire. Additionally, socio-demographic characteristics will be measured. Descriptive analyses will be performed on all variables, with subgroup and country-specific analyses computed. A process evaluation will assess the implementation process using a convergent parallel mixed methods design, inviting teachers and students to participate in an online questionnaire. Semi-structured interviews will further enrich this evaluation.
CONCLUSION/OUTLOOK: The results of the EUthyroid2 project may assist health authorities across participating countries in implementing effective strategies to reduce iodine deficiency and its associated risks. Ultimately, this could lead to a sustainable decrease in the disease burden induced by iodine deficiency.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Henry Völzke
- Phone Number: 0049 3834 86 75 41
- Email: henry.voelzke@med.uni-greifswald.de
Study Locations
-
-
-
Dhaka, Bangladesh, 1216
- Recruiting
- Bangladesh University of Health
-
Contact:
- Mithila Faruque, Dr
- Phone Number: +880 1791-042087
- Email: mithilafaruque@buhs.ac.bd
-
-
-
-
-
Limassol, Cyprus, 3041
- Recruiting
- Cyprus University of Technology
-
Contact:
- Konstantinos C. Makris, PhD
- Phone Number: +357 25002398
- Email: konstantinos.makris@cut.ac.cy
-
-
-
-
-
Greifswald, Germany, 17475
- Recruiting
- University Medicine Greifswald
-
Contact:
- Henry Völzke, Prof. Dr. med.
- Phone Number: 0049 3834 86 75 41
- Email: euthyroid2@uni-greifswald.de
-
-
-
-
Khyber Pakhtunkhwa
-
Peshawar, Khyber Pakhtunkhwa, Pakistan
- Recruiting
- Islamia College Peshawar
-
Contact:
- Rehman Mehmood Khattak, Dr.
- Phone Number: +92 91 9222227
- Email: rehman.mehmood@icp.edu.pk
-
-
-
-
-
Ljubljana, Slovenia, 1000
- Recruiting
- University Medical Centre Ljubljana
-
Contact:
- Simona Gaberšček, MD
- Phone Number: +38 615 223 551
- Email: simona.gaberscek@kclj.si
-
-
-
-
-
Guildford, United Kingdom, GU2 7XH
- Recruiting
- University of Surrey; Queen's University Belfast
-
Contact:
- Sarah Bath, PhD, RD, FHEA
- Phone Number: +44 1483 300800
- Email: s.bath@surrey.ac.uk
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- sufficient language skills to understand the study information, informed consent
Exclusion Criteria:
- none
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Teaching programme on iodine
Educational materials: Iodine Feedback Tool, lecture on the topic of iodine and health, booklet, exercises, group assignments and a webpage
|
Educational materials: Iodine Feedback Tool, lecture on the topic of iodine and health, booklet, exercises, group assignments and a webpage This is a pre/post intervention with no control group.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in awareness
Time Frame: T1 (baseline) to T2 (2-4 weeks) and T3 (6-8 months) in students (13-17 years)
|
1. Change in awareness of iodine and iodine deficiency: Difference in iodine awareness is measured by an iodine awareness questionnaire.
The scoring ranges from 1 to 22 points with higher scores indicating a better outcome of awareness.
|
T1 (baseline) to T2 (2-4 weeks) and T3 (6-8 months) in students (13-17 years)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Changes between teaching modalities
Time Frame: T1 (baseline) to T2 (2-4 weeks) and T3 (6-8 months)
|
Differences in iodine awareness between students taught module A vs module A+B vs module A+C vs module A+B+C.
Changes in iodine awareness are assessed by the iodine awareness questionnaire.
The scoring ranges from 1 to 22 points with higher scores indicating a better outcome of awareness.
|
T1 (baseline) to T2 (2-4 weeks) and T3 (6-8 months)
|
|
Changes in vocational schools, high- and secondary schools
Time Frame: T1 (baseline) to T2 (2-4 weeks) and T3 (6-8 months)
|
Differences in iodine awareness between students in vocational schools vs high schools vs secondary schools.
Changes in iodine awareness are assessed by the iodine awareness questionnaire.
The scoring ranges from 1 to 22 points with higher scores indicating a better outcome of awareness.
|
T1 (baseline) to T2 (2-4 weeks) and T3 (6-8 months)
|
|
Change between age groups and gender distinctions
Time Frame: T1 (baseline) to T2 (2-4 weeks) and T3 (6-8 months)
|
Differences in iodine awareness between girls vs boys. Changes in iodine awareness are assessed by the iodine awareness questionnaire. Differences in iodine awareness between 13-year-olds vs 14-year-olds vs 15-year-olds vs 16-year-olds vs 17-year-olds. Changes in iodine awareness are assessed by the iodine awareness questionnaire. The scoring ranges from 1 to 22 points with higher scores indicating a better outcome of awareness. Gender and age will be self-reported in a socio-demographic questionnaire. |
T1 (baseline) to T2 (2-4 weeks) and T3 (6-8 months)
|
|
Change in iodine intake
Time Frame: T1 (baseline) to T2 (2-4 weeks) and T3 (6-8 months)
|
Dietary iodine intake is assessed through a food frequency questionnaire (FFQ), covering five main categories (cow's milk, fish, eggs, supplements, and salt) and regional components in each country.
Each category is scored based on frequency (portions per day, week, or month), and individual sources are analyzed for iodine intake.
For example, taking supplements 5-7 times a week or consuming a combination of multiple sources of cow's milk, fish and eggs a week may suggest sufficient intake.
Regional differences are also considered, as salt is an iodine source in countries like Pakistan and Bangladesh, but not in the UK or Norway.
The number of iodine sources will be compared before and after the intervention within each country, with a higher number of sources indicating a higher iodine intake).
The number will differ according to the number of sources in each country.
|
T1 (baseline) to T2 (2-4 weeks) and T3 (6-8 months)
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 101095643_2
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Iodine Deficiency
-
DTU National Food InstituteUniversity Hospital Bispebjerg and FrederiksbergRecruitingDiet Habit | Iodine Deficiency | Iodine ToxicityDenmark
-
Universidade do PortoHospital de Braga; NOVA Medical School; Centro Hospitalar De São João, E.P.E.; Centro... and other collaboratorsCompletedIodine Deficiency | Iodine Status in PregnancyPortugal
-
Mahidol UniversityCompleted
-
University of GlasgowCompleted
-
Swiss Federal Institute of TechnologyCompleted
-
Swiss Federal Institute of TechnologyUniversity of Zagreb; Global Alliance for Improved Nutrition; UNICEF; St. Luke's... and other collaboratorsCompletedIodine DeficiencyPhilippines, Switzerland, China, Croatia
-
EUthyroidUK Research and Innovation; EU HorizonRecruitingIodine DeficiencyBangladesh, Norway, Pakistan, Poland, United Kingdom
-
Swiss Federal Institute of TechnologyUNICEF; Pan American Health OrganizationCompletedIodine DeficiencyAntigua and Barbuda, Barbados, Belize, Dominica, Grenada, Jamaica, Saint Kitts and Nevis, Saint Lucia, Saint Vincent and the Grenadines, Trinidad and Tobago
-
Swiss Federal Institute of TechnologyCompletedIodine DeficiencyMorocco
-
qingya tangCompletedPregnancy | Iodine DeficiencyChina
Clinical Trials on Experimental: Intervention group
-
The University of Hong KongHaven of Hope Hospital; The Social Innovation and Entrepreneurship Development...Completed
-
Riphah International UniversityRecruitingEffects of Strength Training on Freestyle Swimming Performance and Core Muscles Strength in SwimmersSports Physical TherapyPakistan
-
The Fourth Affiliated Hospital of Zhejiang University...Recruiting
-
Nanjing Medical UniversityNanjing Maternity and Child Health Care Hospital; Jiangsu Maternity and Child... and other collaboratorsRecruitingQuality Improvement | Premature Infant | Breast-feedingChina
-
Gazi UniversityCompletedMultiple SclerosisTurkey
-
The University of Hong KongHong Kong Young Women's Christian Association; Haven of Hope Hospital; The Social...CompletedTechnologyHong Kong
-
Namik Kemal UniversityEnrolling by invitationPatient Education | Cesarean BirthTurkey (Türkiye)
-
Celal Bayar UniversityCompleted
-
University of Sao Paulo General HospitalCompleted
-
Hellenic Anticancer SocietyNational and Kapodistrian University of AthensCompleted